Wall Street stocks are finally returning to growth after a nervous start to the session, benefiting from a sharp drop in oil prices and hopes for the possible use of strategic reserves by IEA/G7 countries. Indices are recouping their morning losses related to the escalation of the war with Iran and attacks on oil infrastructure, with investors beginning to reposition themselves for a shorter conflict and less risk of a lasting supply shock.
The Dow Jones is up about 0.5%, the S&P 500 is up 0.4%, and the technology-focused Nasdaq Composite is up 0.6%, reflecting improved sentiment after Monday's rebound from the "war low." Brent's decline below $90 eases concerns about a further jump in energy costs and fuels a rotation from defensive to riskier assets, including growth companies represented by the Nasdaq 100. At the same time, the announcement of an extraordinary IEA meeting and signals of readiness to release reserves act as a "safety net" for the stock market, even if physical supply disruptions from the Strait of Hormuz remain a real threat to the stability of the oil market.
For the third time in the last 10 months, the US100 is defending the 200-day EMA zone, and today's upward momentum is pushing the contract above the 100-day EMA. In the medium term, this means that the upward trend defined by these curves remains intact. Oil will be key for further US100 trading, as it is the main factor reflecting fears about the ongoing conflict in the Persian Gulf. The chart below shows the inverse correlation between US100 and OIL seen in recent days.
Source: xStation
🔴US100 Caps Gains Following Trump's Comments
BREAKING: U.S. retail sales above expectations! EUR/USD is gaining!
Market Wrap: European stocks join the bullish rally 🚀 Euro Stoxx +3%
BREAKING: Eurozone PMI stronger than expected 📈 EURUSD gains
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.